Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

i-PRF and A-PRF are promising treatments for hair regrowth in androgenetic alopecia.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

3D ultrasound can detect hair follicle changes and disease phases in alopecia areata.

The C-terminal tail of AHF/trichohyalin is essential for organizing keratin filaments in keratinocytes.

IFHUT shows better hair growth than FUE, but needs improvements in positioning, speed, and accuracy.

HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

The silk fibroin hydrogel with FGF-2-liposome can potentially treat hair loss in mice.

A man regrew hair after using a specific cream for skin treatment.

MAP-2 is crucial for the structure of hair follicles and nails.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

A gene variation is linked to hair thickness in Asians.

Women with severe frontal fibrosing alopecia are more likely to have rosacea.

MAFT is a reliable method for forehead contouring with high patient satisfaction and long-term results.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Women with hair loss have more androgen receptors in certain hair follicles.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

The A allele of the C2 gene increases the risk of lupus, while the G allele may protect against it.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Cosmeceuticals like sunscreens may trigger frontal fibrosing alopecia, but more research is needed.

The commentary suggests that certain hair and skin care products may be linked to frontal fibrosing alopecia, but not sunscreens, and calls for more thorough research on the causes.

3D-ultrasound can non-invasively detect and predict alopecia areata phases and outcomes.